HNK20 antibody nasal drop: Enrollment in ORVX's Phase III trial is complete

OraVax Inc. (ORVX), Cambridge, Mass. Product: HNK20 antibody nasal drop Indication: Prevent viral pneumonia in infants Status: Enrollment in ORVX's Phase III trial is complete, with dosing in the 600...